Mitsui builds new MR factory to tap growing high-index lens demand
Mitsui Chemicals’ Life & Healthcare division revenue increased by 17.9 percent for the first nine months of fiscal 2024/25 to 206.6 billion Japanese yen (€1.3bn), accelerating slightly in Q3. The business unit includes Mitsui’s ophthalmic lens materials, but also other product categories such as agrochemicals or nonwovens. The company does ...
Already an Eyewear Intelligence subscriber? Sign in here.
Subscribe today
Buying a membership today will give you:
- Unlimited access to ewintelligence.com - all insight and analysis available online
- Our executive edition of Eyewear Intelligence (Digital Edition) - the must-read for all decision-makers in the industry
- Weekly E-mail Briefing from the Chief Editor with the lastest analysis and most important industry developments
- Case studies and best practices on business challenges
- Guest chronicles, interviews, insights from industry experts and leaders that are shaping the future of the industry
- Access to over 11,500 articles and analyses in the archive
- Personal library to save articles and track your key content
- Powerful search and intuitive navigation
- Organisation-wide access across offices, people and devices
To continue reading this article register now.